Cargando…

Chloroquine: Can it be a Novel Drug for COVID-19

Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential th...

Descripción completa

Detalles Bibliográficos
Autores principales: Badyal, Dinesh Kumar, Mahajan, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189906/
https://www.ncbi.nlm.nih.gov/pubmed/32363157
http://dx.doi.org/10.4103/ijabmr.IJABMR_141_20
_version_ 1783527589710659584
author Badyal, Dinesh Kumar
Mahajan, Rajiv
author_facet Badyal, Dinesh Kumar
Mahajan, Rajiv
author_sort Badyal, Dinesh Kumar
collection PubMed
description Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.
format Online
Article
Text
id pubmed-7189906
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-71899062020-04-30 Chloroquine: Can it be a Novel Drug for COVID-19 Badyal, Dinesh Kumar Mahajan, Rajiv Int J Appl Basic Med Res New Perspective Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19. Wolters Kluwer - Medknow 2020 2020-04-02 /pmc/articles/PMC7189906/ /pubmed/32363157 http://dx.doi.org/10.4103/ijabmr.IJABMR_141_20 Text en Copyright: © 2020 International Journal of Applied and Basic Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle New Perspective
Badyal, Dinesh Kumar
Mahajan, Rajiv
Chloroquine: Can it be a Novel Drug for COVID-19
title Chloroquine: Can it be a Novel Drug for COVID-19
title_full Chloroquine: Can it be a Novel Drug for COVID-19
title_fullStr Chloroquine: Can it be a Novel Drug for COVID-19
title_full_unstemmed Chloroquine: Can it be a Novel Drug for COVID-19
title_short Chloroquine: Can it be a Novel Drug for COVID-19
title_sort chloroquine: can it be a novel drug for covid-19
topic New Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189906/
https://www.ncbi.nlm.nih.gov/pubmed/32363157
http://dx.doi.org/10.4103/ijabmr.IJABMR_141_20
work_keys_str_mv AT badyaldineshkumar chloroquinecanitbeanoveldrugforcovid19
AT mahajanrajiv chloroquinecanitbeanoveldrugforcovid19